PANCHSHEEL ORGANICS
|
The Current P/E Ratio of PANCHSHEEL ORGANICS is 14.70.
| Share Price | ₹120.6 | Jun 24,2026 |
| Market Cap | ₹159.2 Cr | |
| Earnings-TTM | ₹10.8 Cr | TTM-Standalone Results |
| Price/Earnings | 14.70x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PANCHSHEEL ORGANICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹159.2 Cr] as on Jun 24,2026
(/) Earnings [ ₹10.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 14.70x ]
Thus, for PANCHSHEEL ORGANICS , the investors are currently willing to pay 14.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANCHSHEEL ORGANICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PANCHSHEEL ORGANICS over the last five years.
Historical PE (Price/Earnings) ratio chart of PANCHSHEEL ORGANICS
PE Ratio Performance Analysis for PANCHSHEEL ORGANICS
- PANCHSHEEL ORGANICS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.65x.
- PANCHSHEEL ORGANICS 's operated at median p/e ratio of 14.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PANCHSHEEL ORGANICS 's p/e ratio peaked in Mar2022 at 18.37x.
- PANCHSHEEL ORGANICS 's p/e ratio hit its five-year low in Mar2021 of 4.25x.
How does PANCHSHEEL ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PANCHSHEEL ORGANICS | 10.83 | 14.70 | 159.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.90 | 449,803.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.79 | 179,219.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 71.29 | 152,417.0 |
| CIPLA LTD | 3,869.79 | 30.01 | 116,116.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.75 | 110,874.0 |
| MANKIND PHARMA LTD | 1,926.41 | 53.08 | 102,256.0 |
| LUPIN LTD | 5,355.47 | 20.22 | 108,264.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.81 | 109,636.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.14 | 88,015.6 |
| LAURUS LABS LTD | 889.85 | 88.27 | 78,549.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANCHSHEEL ORGANICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 14.70x |
| Max industry PE | 88.27x |
| Median industry PE | 30.01x |
| Average industry PE | 41.81x |
You may also like the below Video Courses